Bristol-Myers Squibb bms.com


Public list: BIO 2016 (619) Pharma Startups (4743)

Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company committed to discovering, developing, and delivering medicines that help patients prevail over serious diseases.

Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company committed to discovering, developing, and delivering medicines that help patients prevail over serious diseases.

Company (Alive / Active)

Phone: 800-332-2056

Fax:

430 E. 29th Street
14th Floor
New York, 10016
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Bristol-Myers Squibb $0M Apr 7, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Bristol-Myers Squibb Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Gdf-8 inhibitors Feb 15, 2016 May 29, 2018 Patent
Lactam-containing compounds and derivatives thereof as factor xa inhibitors Nov 07, 2016 May 22, 2018 Patent
Substituted pyridinones as mgat2 inhibitors Jun 10, 2015 May 22, 2018 Patent
Enantioselective synthesis of pyrroloindole compounds Sep 28, 2017 May 15, 2018 Patent
Furopyridine compounds for the treatment of hepatitis c Aug 04, 2015 May 01, 2018 Patent
See all 827 patents